Research and Markets: Vancomycin-Resistant Enterococcus Faecium Infections Global Clinical Trials Review, H2, 2015 - Analysis & Technologies Report

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/kxqfqd/vancomycinresista) has announced the addition of the "Vancomycin-Resistant Enterococcus Faecium Infections Global Clinical Trials Review, H2, 2015" report to their offering.

This clinical trial report, 'Vancomycin-Resistant Enterococcus Faecium Infections Global Clinical Trials Review, H2, 2015' provides an overview of Vancomycin-Resistant Enterococcus Faecium Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Vancomycin-Resistant Enterococcus Faecium Infections. It includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

Key Topics Covered:

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Benefits of this Report:

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market

Companies Mentioned:

  • Alvogen, Inc.
  • Pfizer Inc.
  • MicuRx Pharmaceuticals, Inc.
  • LegoChem Biosciences, Inc
  • CPR Pharma Services Pty Ltd
  • Allergan Plc

For more information visit http://www.researchandmarkets.com/research/kxqfqd/vancomycinresista

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases, Clinical Trials

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases, Clinical Trials